Langan-Fahey SM - Search Results

1

Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.

Gibson DF, Johnson DA, Goldstein D, Langan-Fahey SM, Borden EC, Jordan VC. Gibson DF, et al. Among authors: langan fahey sm. Breast Cancer Res Treat. 1993;25(2):141-50. doi: 10.1007/BF00662139. Breast Cancer Res Treat. 1993. PMID: 8347846

2

Reversible control of oestradiol-stimulated growth of MCF-7 tumours by tamoxifen in the athymic mouse.

Iino Y, Wolf DM, Langan-Fahey SM, Johnson DA, Ricchio M, Thompson ME, Jordan VC. Iino Y, et al. Among authors: langan fahey sm. Br J Cancer. 1991 Dec;64(6):1019-24. doi: 10.1038/bjc.1991.457. Br J Cancer. 1991. PMID: 1764361 Free PMC article.

3

Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer.

Langan-Fahey SM, Tormey DC, Jordan VC. Langan-Fahey SM, et al. Eur J Cancer. 1990;26(8):883-8. doi: 10.1016/0277-5379(90)90191-u. Eur J Cancer. 1990. PMID: 2145931

4

Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.

Murphy CS, Langan-Fahey SM, McCague R, Jordan VC. Murphy CS, et al. Among authors: langan fahey sm. Mol Pharmacol. 1990 Nov;38(5):737-43. Mol Pharmacol. 1990. PMID: 2233701

5

Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts.

Robinson SP, Langan-Fahey SM, Jordan VC. Robinson SP, et al. Among authors: langan fahey sm. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1769-76. doi: 10.1016/0277-5379(89)90347-7. Eur J Cancer Clin Oncol. 1989. PMID: 2632258

6

The effects of intermittent progesterone upon tamoxifen inhibition of tumor growth in the 7,12-dimethylbenzanthracene rat mammary tumor model.

Gibson DF, Johnson DA, Langan-Fahey SM, Lababidi MK, Wolberg WH, Jordan VC. Gibson DF, et al. Among authors: langan fahey sm. Breast Cancer Res Treat. 1993 Sep;27(3):283-7. doi: 10.1007/BF00665699. Breast Cancer Res Treat. 1993. PMID: 8312587

7

Investigation of the mechanism of tamoxifen-stimulated breast tumor growth with nonisomerizable analogues of tamoxifen and metabolites.

Wolf DM, Langan-Fahey SM, Parker CJ, McCague R, Jordan VC. Wolf DM, et al. Among authors: langan fahey sm. J Natl Cancer Inst. 1993 May 19;85(10):806-12. doi: 10.1093/jnci/85.10.806. J Natl Cancer Inst. 1993. PMID: 8487325

8

Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells.

Jeng MH, Langan-Fahey SM, Jordan VC. Jeng MH, et al. Among authors: langan fahey sm. Endocrinology. 1993 Jun;132(6):2622-30. doi: 10.1210/endo.132.6.8504763. Endocrinology. 1993. PMID: 8504763

9

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.

Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Jordan VC, et al. J Natl Cancer Inst. 1991 Oct 16;83(20):1488-91. doi: 10.1093/jnci/83.20.1488. J Natl Cancer Inst. 1991. PMID: 1920495

10

Suppression of mouse mammary tumorigenesis by long-term tamoxifen therapy.

Jordan VC, Lababidi MK, Langan-Fahey S. Jordan VC, et al. J Natl Cancer Inst. 1991 Apr 3;83(7):492-6. doi: 10.1093/jnci/83.7.492. J Natl Cancer Inst. 1991. PMID: 2005632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters